ARK LEG Limited Medication Access

Published on: Apr 23, 2025

On Apr. 16, ARK LEG enacted bill prohibiting limited medication access.

  • ARK LEG enacted bill HB 1531 relating to restriction of prescription medications.
  • Amends ARK LEG 20-64-1 by adding new section on limited distribution of medication.
  • Bill Provisions
  • Pharmaceutical manufacturers shall not restrict prescription medications more than 3 months after launch of new product to a limited distribution network of pharmacies.
  • Without having similar access and allowing for upon request by pharmacy at least local network of academic medical center access, geographic diversity of access within State
  • Diverse access for local for-profit and nonprofit pharmacies in good standing with the board and the pharmacy meeting medication specific FDA guidance or requirements.
  • Manufacturer that requests for restricted networks for 6 months or longer shall present to board to explain how restriction will support and not hinder the mission of the board
  • Board mission to promote, preserve, protect public health, safety, welfare of citizens.
  • Public hearing shall be called as soon as possible to discuss and approve or deny any request for permanent limited network or restriction relating to Class A pharmacies.
  • State government, public plan sponsor shall not pay for prescription drugs from a manufacturer who is noncompliant with this section unless board granted a waiver.
  • If pharmaceutical manufacturer or manufacturer for Medicaid is not in compliance with this section, the board shall fine the manufacturer $10,000 per day of noncompliance.
  • Does not apply to the State and Public School Life and Health Insurance Program.
  • Legislative History
  • On Feb. 19, 2025, bill was introduced in House; on Apr. 1, 2025, bill passed House.
  • On Apr. 1, 2025, bill was introduced in Senate; on Apr. 8, 2025, bill passed Senate.
  • On Apr. 10, 2025, House concurred; On Apr. 16, 2025, bill signed by governor.
  • Effectiveness
  • Act effective 91 days after legislature adjourned sine die (May 5), so Aug. 4, 2025.
  • Pharmaceutical manufacturers shall be in compliance with act by Sep. 1, 2026.
Regulators
ARK LEG
Entity Types
CNSM; Corp; Ins
Reference
PR, Act 630, Bill HB1531, 4/16/2025; Citation: ARK LEG 20-64-1;
Functions
Claims/Accelerated Benefits; Compliance; Financial; Legal; Operations; Reporting; Risk
Countries
United States of America
Category
State
N/A
Products
Insurance; Insurance-Health
Rule Type
Final
Regions
Am
Rule Date
Apr 16, 2025
Effective Date
Aug 4, 2025
Rule ID
251432
Linked to
N/A
Reg. Last Update
Apr 16, 2025
Report Section
US Insurance